| scholarly article | Q13442814 |
| P50 | author | Peter D. Mace | Q42423701 |
| Bernhard C Lechtenberg | Q81790787 | ||
| P2093 | author name string | Elena B Pasquale | |
| Stefan J Riedl | |||
| Philip E Dawson | |||
| Ilaria Lamberto | |||
| Erika J Olson | |||
| P2860 | cites work | MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 |
| EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice | Q27320846 | ||
| Crystal Structure and NMR Binding Reveal That Two Small Molecule Antagonists Target the High Affinity Ephrin-binding Channel of the EphA4 Receptor | Q27651657 | ||
| Structural Plasticity of Eph Receptor A4 Facilitates Cross-Class Ephrin Signaling | Q27657815 | ||
| Structural Characterization of the EphA4-Ephrin-B2 Complex Reveals New Features Enabling Eph-Ephrin Binding Promiscuity | Q27658020 | ||
| Structurally encoded intraclass differences in EphA clusters drive distinct cell responses | Q27678839 | ||
| Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5 | Q27679723 | ||
| Overview of the CCP4 suite and current developments | Q27860782 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM | Q27861099 | ||
| Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport | Q28251532 | ||
| A quantitative analysis of kinase inhibitor selectivity | Q28264038 | ||
| The future of peptide-based drugs | Q28281702 | ||
| Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord | Q28584025 | ||
| EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers | Q29347252 | ||
| Anatomy of hot spots in protein interfaces | Q29616238 | ||
| Eph-ephrin bidirectional signaling in physiology and disease | Q29617975 | ||
| Eph receptor signalling casts a wide net on cell behaviour | Q29619988 | ||
| Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs | Q31108703 | ||
| Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity | Q31144324 | ||
| EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth | Q33257109 | ||
| Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease | Q33919522 | ||
| Attenuation of scratch-induced reactive astrogliosis by novel EphA4 kinase inhibitors. | Q33953835 | ||
| Eph receptors and ephrins in cancer: bidirectional signalling and beyond | Q34021365 | ||
| Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome. | Q34026097 | ||
| Protein dynamics at Eph receptor-ligand interfaces as revealed by crystallography, NMR and MD simulations | Q34141080 | ||
| Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations | Q34170551 | ||
| HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery | Q34564346 | ||
| Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion | Q36223133 | ||
| Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor | Q36914295 | ||
| Acute delivery of EphA4-Fc improves functional recovery after contusive spinal cord injury in rats | Q36947648 | ||
| RNAi screen for rapid therapeutic target identification in leukemia patients | Q37187716 | ||
| Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport | Q37579588 | ||
| Targeting Eph receptors with peptides and small molecules: progress and challenges | Q37951723 | ||
| Eph receptors at synapses: implications in neurodegenerative diseases. | Q37961534 | ||
| Therapeutic perspectives of Eph-ephrin system modulation. | Q38167588 | ||
| EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans | Q38322311 | ||
| MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells | Q39274635 | ||
| Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases | Q39567597 | ||
| Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. | Q39932205 | ||
| EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line | Q39940130 | ||
| Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors | Q41875227 | ||
| EphA4 signaling in juveniles establishes topographic specificity of structural plasticity in the hippocampus | Q43133200 | ||
| Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling | Q44259200 | ||
| Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke | Q44310626 | ||
| Targeting the EphA4 receptor in the nervous system with biologically active peptides | Q44707568 | ||
| EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions | Q46915994 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2787-2795 | |
| P577 | publication date | 2014-10-14 | |
| P1433 | published in | ACS Chemical Biology | Q165583 |
| P1476 | title | Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor | |
| P478 | volume | 9 |
| Q90250053 | Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling |
| Q60933281 | EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions |
| Q49709391 | EphB4: A promising target for upper aerodigestive malignancies |
| Q35634594 | High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists |
| Q33882055 | Identification and characterization of Nanobodies targeting the EphA4 receptor. |
| Q41063994 | Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability |
| Q55367685 | Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer's Disease. |
| Q46499375 | Potent and Selective EphA4 Agonists for the Treatment of ALS. |
| Q46167371 | SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration |
| Q30398451 | Targeting kinase signaling pathways with constrained peptide scaffolds |
| Q26799461 | Targeting the Eph System with Peptides and Peptide Conjugates |
| Q51503040 | The Role of EphA4 Signaling in Radiation-Induced EMT-Like Phenotype in Colorectal Cancer Cells. |
| Q57812327 | Therapeutic potential of targeting the Eph/ephrin signaling complex |
Search more.